42 research outputs found
Impedance spectroscopy measurements to study physio-chemical processes in lime-based composites
Detection of Sclerotinia sclerotiorum in soybean seeds by conventional and quantitative PCR techniques
Zoledronate in the prevention of Paget's (ZiPP) : protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone.
Introduction Paget’s disease of bone (PDB) is characterised by increased and disorganised bone remodelling affecting one or more skeletal sites. Complications include bone pain, deformity, deafness and pathological fractures. Mutations in sequestosome-1 (SQSTM1) are strongly associated with the development of PDB. Bisphosphonate therapy can improve bone pain in PDB, but there is no evidence that treatment alters the natural history of PDB or prevents complications. The Zoledronate in the Prevention of Paget’s disease trial (ZiPP) will determine if prophylactic therapy with the bisphosphonate zoledronic acid (ZA) can delay or prevent the development of PDB in people who carry SQSTM1 mutations.
Methods and analysis People with a family history of PDB aged >30 years who test positive for SQSTM1 mutations are eligible to take part. At the baseline visit, participants will be screened for the presence of bone lesions by radionuclide bone scan. Biochemical markers of bone turnover will be measured and questionnaires completed to assess pain, health-related quality of life (HRQoL), anxiety and depression. Participants will be randomised to receive a single intravenous infusion of 5 mg ZA or placebo and followed up annually for between 4 and 8 years at which point baseline assessments will be repeated. The primary endpoint will be new bone lesions assessed by radionuclide bone scan. Secondary endpoints will include changes in biochemical markers of bone turnover, pain, HRQoL, anxiety, depression and PDB-related skeletal events
Long-range Angular Correlations On The Near And Away Side In P-pb Collisions At √snn=5.02 Tev
7191/Mar294
Predictors of the ability of innovation in organizations: Systematic literature review [Predictores de la capacidad de innovación en las organizaciones: Revisión sistemática de literatura]
This proposal is part of a much larger work, this first phase allowed to answer about the determinants of innovation capabilities in organizations for this purpose the Systematic Literature Review (RSL) was adopted using different equations search. From a base of 530 articles they were finally selected 108. The revision allowed many different definitions of the concept, as well as to pinpoint the determinants of innovation capability. In the same way a model with predictors of this capacity was proposed